SOPHiA GENETICS (SOPH) Long-Term Deferred Tax (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Long-Term Deferred Tax data on file, last reported at $1.8 million in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Deferred Tax rose 3.62% year-over-year to $1.8 million; the trailing twelve-month figure through Dec 2025 stood at $1.8 million (up 3.62% YoY), and the FY2025 full-year result was $1.8 million, up 3.62% from the prior year.
• Long-Term Deferred Tax advanced to $1.8 million in Q4 2025, from $1.7 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $2.0 million in Q2 2021 to a low of $1.6 million in Q3 2022.
• A 5-year average of $1.8 million and a median of $1.8 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax decreased 18.77% in 2022 and advanced 23.81% in 2023, its largest moves.
• Tracing SOPH's Long-Term Deferred Tax over 5 years: stood at $2.0 million in 2021, then decreased by 2.51% to $1.9 million in 2022, then slipped by 11.34% to $1.7 million in 2023, then increased by 2.73% to $1.8 million in 2024, then gained by 3.62% to $1.8 million in 2025.
• Business Quant data shows SOPH's Long-Term Deferred Tax at $1.8 million in Q4 2025, $1.7 million in Q3 2025, and $1.8 million in Q2 2025.